Neurogene shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Neurogene
Tip: Access up to 7 years of quarterly data
All positions including Neurogene held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neurogene by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $509 | 10 | 50.90 |
2023-12-31 | $194 | 10 | 19.40 |